eISSN: None / ISSN: 1673-5269
Register
Login
Volume 30 Issue 1 (2023): None
Articles
Research progress of integrin in hepatocellular carcinoma; 整合素在肝细胞癌中的研究进展
61-66
Research progress on the application of PD-1/PD-L1 inhibitors in advanced lung cancer with epidermal growth factor receptor mutation population; HER2 阳性乳腺癌患者延迟确诊对确诊分期影响的研究
54-60
Models for cervical cancer assistant diagnosis based on machine learning algorithms; 基于机器学习算法的宫颈癌辅助诊断模型
48-53
Association between delays in diagnosis and clinical stage of HER2-positive breast cancer; HER2 阳性乳腺癌患者延迟确诊对确诊分期影响的研究
43-47
A quality assurance process for measuring MR-linac registration deviation; 一种测量MR-linac 配准误差的质量保证流程研究
36-42
Analysis of the influencing factors of lung metastasis time and prognosis after cervical squamous cell carcinoma surgery; 宫颈鳞癌术后肺转移时间与预后影响因素分析
30-35
Ambral reduces the chemosensitivity of breast cancer cells via the Akt-Bad-Bcl-2 pathway; 自噬/Beclinl调节因子1通过Akt-Bad-Bcl-2通路降低乳腺癌化疗敏感性
20-35
Experimental study on the effect of ultrasound-targeted microbubble destruction mediated CTLA-4 gene target inhibition on T lymphocyte immune activity and tumor immune killing efficiency; 超声微泡介导CTLA -4 基因靶向抑制对T 淋巴细胞
14-19
micro-PET/CT comparative study of drug 68Ga-SC691 targeting PSMA in two animal models with prostate cancer; 靶向前列腺特异性膜抗原药物68Ga-SC691 两种前列腺癌小鼠模型microPET/CT 比较研究
7-13
Analysis of incidence and mortality of stomach cancer in urban and rural area of Shandong Province, 2018; 2018年山东省城乡居民胃癌发病与死亡水平分析
1-6

For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.

 

Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org

 

Address: Jinan, Shandong Province, Ji Yan Road #440 - Location

 

WhatsApp Support: For inquiries and assistance, please contact our support team via WhatsApp: https://wa.me/919707682512 

Open Access Publication